
Tennessee researches aim nuclear technology at ovarian cancer
ORNL, UT researchers unite to develop targeted radiation therapies that could transform treatment for one of the state's deadliest diseases.
Contact VP of Investor Development & Experience Amanda O’Dell by email or call 865-246-2605.